Visualitzacions | |
---|---|
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial | 52 |
gener 2024 | febrer 2024 | març 2024 | abril 2024 | maig 2024 | juny 2024 | juliol 2024 | |
---|---|---|---|---|---|---|---|
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial | 0 | 17 | 0 | 7 | 5 | 13 | 10 |
Visualitzacions | |
---|---|
artconlli_a2018_tabernero_josep_efficacy_Sym004.pdf | 7 |
Visualitzacions | |
---|---|
Estats Units | 34 |
Xina | 7 |
Canadà | 2 |
Espanya | 1 |
Visualitzacions | |
---|---|
Menlo Park | 24 |
Shanghai | 6 |
Oakland | 5 |
San Diego | 4 |
Ottawa | 2 |
Barcelona | 1 |
Guangzhou | 1 |
Jackson | 1 |